CVS Health Corporation $CVS Position Lowered by Value Partners Investments Inc.

Value Partners Investments Inc. trimmed its position in CVS Health Corporation (NYSE:CVS) by 3.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 548,893 shares of the pharmacy operator’s stock after selling 16,695 shares during the period. CVS Health accounts for about 3.4% of Value Partners Investments Inc.’s investment portfolio, making the stock its 16th biggest holding. Value Partners Investments Inc.’s holdings in CVS Health were worth $41,360,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of CVS. Avion Wealth grew its position in shares of CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 189 shares in the last quarter. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health during the 2nd quarter valued at approximately $30,000. Bell Investment Advisors Inc boosted its holdings in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 248 shares during the period. Front Row Advisors LLC boosted its holdings in CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares during the period. Finally, Roxbury Financial LLC raised its holdings in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the subject of several research reports. Evercore ISI lifted their price target on shares of CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Zacks Research cut shares of CVS Health from a “strong-buy” rating to a “hold” rating in a report on Monday, September 8th. Argus upped their target price on CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a report on Tuesday, November 4th. Wolfe Research increased their price target on CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, December 8th. Finally, Morgan Stanley boosted their price objective on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $94.67.

CVS Health Stock Performance

CVS opened at $78.00 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. The business’s 50 day moving average is $79.06 and its 200-day moving average is $72.71. The stock has a market cap of $99.01 billion, a PE ratio of 205.26, a price-to-earnings-growth ratio of 0.77 and a beta of 0.48. CVS Health Corporation has a twelve month low of $43.65 and a twelve month high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The business had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.